Telix Pharmaceuticals

New Capabilities

Holds first FDA-approved FET-PET imaging drug for glioma

Brain cancer doctors face a maddening problem: after radiation and chemo, standard MRI scans often can't tell whether a suspicious spot is tumor regrowth or treatment-related change. The two scenarios call for opposite treatments. The FDA just approved a test that settles the question.

Updated 1 hour ago